Illinois Finance Authority Chicago Charter School Foundation; Charter Schools Jan 07

  • ID: 1722848
  • January 2007
  • Region: Illinois
  • Standard & Poors
1 of 3

The 'BBB' rating on Illinois Finance Authority's series 2007 charter school revenue project and refunding bonds, issued on behalf of the Chicago Charter School Foundation, reflects the following: Gross revenue pledge of the foundation; A solid framework for charter schools in Illinois, given legal and financial parameters; The foundation already successfully completed a charter renewal process; the charter was renewed in late 2001 for the five-year period through June 30, 2007; The charter covers multiple school sites and has a large current enrollment of 5,859 for the 2006-2007 school year. Actual student growth rates have been consistent with earlier projections and have reached levels required to provide adequate debt service coverage; Enrollment growth and demand has been demonstrated, with annually...

Companies mentioned in this report are:
- Chicago Charter Sch Foundn
- Illinois Fin Auth

Action: New Rating

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research Type: Full Analysis

Note: Product cover images may vary from those shown
2 of 3

- Chicago Charter Sch Foundn
- Illinois Fin Auth

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown




Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.